Proximal Gastrectomy



Proximal Gastrectomy


Sushanth Reddy

Martin J. Heslin





PATIENT HISTORY AND PHYSICAL FINDINGS



  • Patients typically present with difficulty swallowing, dysphagia, upper gastrointestinal (GI) bleeding, or reflux symptoms, especially in the setting of unexplained weight loss. Initial diagnostic evaluation typically includes an esophagogastroduodenoscopy (EGD) with biopsy showing malignancy.


  • A thorough history and physical examination should be performed prior to surgery. Particular attention should be paid to cardiac and pulmonary comorbidities and nutritional status. Risk factors for cancer including acid reflux disease, history of Barrett’s esophagus, and tobacco use should be identified.


  • Patients who have disease in the proximal to midesophagus should not undergo proximal gastrectomy.1 These patients should be considered for either an Ivor-Lewis (Part 1, Chapter 30) or transhiatal esophagectomy (Part 1, Chapter 29).


  • All patients with cancer should undergo staging prior to consideration for surgery.


  • Patients with high-grade dysplasia or T1 tumors without lymph node metastases should be considered for surgery first. Patients with advanced tumors (T2 or greater) or those with lymph node involvement should be considered for upfront (neoadjuvant) chemotherapy and radiation therapy.2,3 Those patients who are nutritionally depleted should have a feeding jejunostomy tube placed prior to initiating therapy.4


  • Following completion of chemotherapy and radiation therapy, patients should be restaged. The presence of distant metastases is a contraindication for surgery.


  • The period of upfront therapy allows for optimization of cardiac and pulmonary comorbidities prior to surgery.


IMAGING AND OTHER DIAGNOSTIC STUDIES



  • All patients should undergo staging evaluation prior to surgery. Endoscopic ultrasound (EUS) is used to identify tumor depth (T stage) and regional lymph node metastases (N stage). Computed tomography (CT) scan or positron emission tomography (PET) scan is used to identify distant metastases. The liver is the most common site of distant metastases for adenocarcinoma and squamous cell carcinoma (the two most common tumor histologies).


  • Staging should be repeated after the completion of upfront chemotherapy prior to surgery.


  • The celiac axis anatomy should be carefully studied prior to surgery to look for anomalies. Specific attention should be paid toward an accessory or replaced left hepatic artery within the gastrohepatic ligament.


SURGICAL MANAGEMENT


Preoperative Planning



  • Many patients with gastric or esophageal malignancy have comorbid conditions related to age or tobacco use. These patients should undergo optimization of their comorbidities prior to surgery.


  • Anesthesia should consider placement of an arterial monitoring catheter and/or a central venous catheter. During hiatal dissection, the heart may be compressed and invasive monitoring can be useful in guiding resuscitation in the operating room.


  • A nasogastric (NG) tube will be placed during the operation. It may not be possible to pass an NG tube prior to removal of the tumor (if it is obstructing). The surgeon should have good communication with anesthesia in regard to NG tube position as it will be manipulated through the operation.


Positioning



  • The patient is positioned with both arms at 90 degrees with the torso. This will facilitate with exposure by spreading the lower ribs laterally. Alternatively the right arm can be tucked to the patient’s side to aid in attachment of the self-retaining retractor device to the operating room table. If a feeding jejunostomy tube has already been placed, the tube should be prepped into the sterile field.